PiR48444 inhibits MSC osteogenic differentiation and bone regeneration via targeting METTL7A/eIF4E-mediated BMP2 m6A
Zhichao Zheng1,2, Xingyang Li1, Wenguang Qin1
1School and Hospital of Stomatology, Guangdong Engineering Research Center of Oral Restoration and Reconstruction & Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou Medical University, Guangzhou, China.
Abstract:
Non-coding RNAs, including piwi-interacting RNAs (piRNAs), are known to regulate osteogenic differentiation in bone marrow-derived mesenchymal stem cells (BMSCs); their role in mesenchymal stem cells (MSCs) from diverse origins remains unclear. In this study, we identified piR48444 as a key regulator that is downregulated during the osteogenic differentiation of stem cells from exfoliated deciduous teeth (SHED) but is upregulated in inflamed and aged BMSCs. Functionally, piR48444 inhibited, while its knockdown enhanced osteogenic differentiation across MSCs from multiple sources. Notably, piR48444-depleted MSCs exhibited superior bone defect repair capacity. PiR48444 antagomir promoted bone regeneration in LPS-induced osteolysis mice and aging mice. Mechanistically, we demonstrated that piR48444 targets METTL7A, suppressing BMP2 mRNA m6A methylation. Furthermore, we discovered that the METTL7A/eIF4E complex binds to BMP2 mRNA, thereby enhancing its translational efficiency. Our findings establish piR48444 as a negative regulator of MSC osteogenesis through METTL7A-mediated BMP2 m6A methylation, highlighting its potential as a therapeutic target to enhance MSC-based bone regeneration strategies.
Insights
Piwi-interacting RNA 48444 (piR48444) negatively regulates mesenchymal stem cell (MSC) osteogenesis by targeting METTL7A and BMP2 mRNA methylation. Its inhibition enhances bone regeneration, suggesting piR48444 as a therapeutic target for bone repair.
Area of Science:
- Stem cell biology
- RNA biology
- Regenerative medicine
Background:
- Non-coding RNAs, including piwi-interacting RNAs (piRNAs), regulate osteogenic differentiation in mesenchymal stem cells (MSCs).
- The specific role of piRNAs in MSCs from various sources and their involvement in bone regeneration remain largely unexplored.
- Understanding piRNA regulation is crucial for advancing MSC-based therapies.
Purpose of the Study:
- To investigate the role of piR48444 in osteogenic differentiation of MSCs from diverse origins.
- To elucidate the underlying molecular mechanisms of piR48444 in regulating osteogenesis.
- To evaluate the therapeutic potential of targeting piR48444 for bone regeneration.
Main Methods:
- Identification and characterization of piR48444 expression in different MSCs.
- Functional assays to assess the impact of piR48444 manipulation on osteogenic differentiation.
- In vivo studies using mouse models for bone defect repair and osteolysis.
- Mechanistic studies involving RNA-protein interactions and mRNA methylation analysis.
Main Results:
- piR48444 was found to be downregulated during osteogenic differentiation of stem cells from exfoliated deciduous teeth (SHED) and upregulated in inflamed/aged bone marrow-derived mesenchymal stem cells (BMSCs).
- Overexpression of piR48444 inhibited osteogenesis, while its knockdown enhanced differentiation and bone defect repair capacity in MSCs.
- piR48444 antagomir administration promoted bone regeneration in vivo.
- Mechanistically, piR48444 targets METTL7A, suppressing BMP2 mRNA N6-methyladenosine (m6A) methylation, thereby inhibiting osteogenesis.
Conclusions:
- piR48444 acts as a negative regulator of MSC osteogenesis via the METTL7A-mediated BMP2 mRNA m6A methylation pathway.
- Targeting piR48444 offers a promising therapeutic strategy to enhance MSC-based bone regeneration.
- Further research into piRNA regulation could unlock novel approaches for treating bone disorders.
Related Concept Videos
Feedback Inhibition
Enzyme Inhibition
Inhibition of Cdk Activity
Receptor-mediated Endocytosis
Whole Body Regeneration
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...


